Pertussis Vaccine Market 2026 unlocking growth with immunization programs

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Pertussis Vaccine Market Over The 2026–2030 Period?

The pertussis vaccine market size has experienced consistent expansion in recent times. It is anticipated to grow from $5.65 billion in 2025 to $5.82 billion in 2026, reflecting a compound annual growth rate (CAGR) of 2.9%. The market’s historical development can be attributed to high childhood immunization coverage, national vaccination programs led by governments, past occurrences of whooping cough outbreaks, the integration of the pertussis vaccine into standard immunization schedules, and the availability of whole-cell vaccines.

The pertussis vaccine market size is anticipated to experience consistent expansion in the coming years. It is projected to reach $6.82 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.1%. This growth during the projected timeframe is attributable to several factors, including heightened awareness regarding adult pertussis vaccination, an uptick in maternal immunization recommendations, continuous progress in vaccine safety and efficacy, broadened healthcare accessibility within developing economies, and increased development of combination vaccines. Key trends shaping the forecast period encompass a growing uptake of acellular pertussis vaccines, an intensified emphasis on booster immunization programs, the wider availability of combination vaccines incorporating pertussis, an increase in adult and maternal pertussis vaccinations, and reinforced government immunization initiatives.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13023&type=smp

Which Economic Or Industry Drivers Are Impacting The Pertussis Vaccine Market?

The increasing number of births is propelling the expansion of the pertussis vaccine market into the future. Childbirth refers to the process of a mother delivering a baby, which concludes pregnancy, a period where a fetus grows inside the uterus, initiating the baby’s life beyond the womb. The pertussis vaccine is mainly administered to children to safeguard them against whooping cough and various other serious, potentially fatal illnesses. For example, data from January 2023, sourced from a report by the Centers for Disease Control and Prevention, a national public health body in the US, indicated that the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, relative to the figures from 2022. Thus, the growing childbirth rates are boosting the expansion of the pertussis vaccine market.

How Is The Pertussis Vaccine Market Segmented Across Key Categories?

The pertussis vaccine market covered in this report is segmented –

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine, Tdap (Tetanus, Diphtheria and Pertussis) Vaccine

2) By Vaccine Type: Whole-Cell Vaccine, Acellular Vaccine

3) By Application: Children, Adults, Infants

4) By End-User: Vaccination Centers, Hospitals, Clinics

Subsegments:

1) By DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine: Pediatric DTaP Vaccine, Combination Vaccines With DTaP

2) By Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine: Adolescent Tdap Vaccine, Adult Tdap Vaccine

Which Upcoming Trends Are Expected To Influence The Pertussis Vaccine Market?

Leading firms within the pertussis vaccine market are concentrating their efforts on creating sophisticated immunization remedies and obtaining necessary regulatory clearances to bolster maternal and infant defense against whooping cough. Such endeavors seek to boost vaccine availability, broaden its advised application during pregnancy, and diminish pertussis-associated illness in newborns. Illustratively, in January 2023, Sanofi S.A., a biopharmaceutical entity based in France, obtained U.S. FDA authorization for the wider application of its Adacel (Tdap) vaccine during the third trimester of pregnancy, thereby facilitating maternal immunization to assist in safeguarding infants under two months old who face the highest risk of severe pertussis infection. This sanction empowers healthcare practitioners to actively immunize expectant mothers, guaranteeing the transfer of protective antibodies to the newborn prior to delivery. Consequently, infants acquire early protection against pertussis, bridging the immunity deficit until they are eligible for their own immunizations.

Who Are The Dominant Players Shaping The Pertussis Vaccine Market Landscape?

Major companies operating in the pertussis vaccine market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, CSL Limited, Serum Institute of India, Biological E. Limited, Bharat Biotech International Limited, Panacea Biotec Limited, PT Bio Farma, Walvax Biotechnology Co. Ltd., Beijing Minhai Biotechnology Co. Ltd., Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Chiron Corporation, Sinovac Biotech Ltd., Takeda Pharmaceutical Company, Novartis AG, Johnson & Johnson

Read the full pertussis vaccine market report here:

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

What Are The Top-Performing Regions Within The Pertussis Vaccine Market?

North America was the largest region in the pertussis vaccine market in 2025. The regions covered in the pertussis vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pertussis Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13023&type=smp

Browse Through More Reports Similar to the Global Pertussis Vaccine Market 2026, By The Business Research Company

Pertussis Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Porcine Epidemic Diarrhea Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/porcine-epidemic-diarrhea-vaccines-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795